Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 6, 2025 CURRENT REPORT
8-K Dec 27, 2024 CURRENT REPORT
10-K Dec 27, 2024 ANNUAL REPORT
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
4 Dec 16, 2024
8-K Nov 12, 2024 CURRENT REPORT
SC 13G/A Nov 6, 2024 CTOR 13G/A
8-K Sep 13, 2024 CURRENT REPORT
8-K Sep 5, 2024 CURRENT REPORT
SC 13G/A Sep 5, 2024 SC 13G/A
4/A Aug 30, 2024
4/A Aug 30, 2024
4/A Aug 30, 2024
4/A Aug 30, 2024
8-K/A Aug 26, 2024 AMENDMENT NO. 1 TO FORM 8-K
8-K Aug 16, 2024 CURRENT REPORT
SC 13D Aug 16, 2024 SCHEDULE 13D
← Newer Page 6 of 11 · 268 filings Older →